Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 7/20 | 0.39 |
| ▸ | CDK1 | P06493 | 6/20 | 0.39 |
| ▸ | CCNB2 | O95067 | 5/20 | 0.39 |
| ▸ | CCNB1 | P14635 | 5/20 | 0.39 |
| ▸ | CCNB3 | Q8WWL7 | 5/20 | 0.39 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.36 |
| ▸ | TSPO | P30536 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | RXRA | P19793 | 2/20 | 0.32 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19978100 | 0.88 | GSK3B (0.39) | GSK3BCDK1CCNB2CCNB1CCNB3 | |
| SCHEMBL19978107 | 0.88 | PGR (0.33) | MAPT | |
| SCHEMBL19978118 | 0.86 | CYP1A2 (0.33) | MAPT | |
| SCHEMBL19978106 | 0.85 | GRIK2 (0.40) | MAPTPDE4BSMN1; SMN2 | |
| SCHEMBL19978109 | 0.85 | DNMT1 (0.39) | DNMT1 | |
| SCHEMBL19978119 | 0.79 | GSK3B (0.48) | GSK3BCDK1CCNB2CCNB1CCNB3 | |
| SCHEMBL19978114 | 0.76 | PGR (0.34) | MAPT | |
| SCHEMBL19978115 | 0.74 | GRIK2 (0.39) | MAPTSMN1; SMN2 | |
| SCHEMBL19978098 | 0.74 | PGR (0.38) | DNMT1 | |
| SCHEMBL19978105 | 0.73 | PRKD3 (0.31) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180079841-A1 | METALLOCENE SUPPORTED CATALYST AND METHOD FOR PREPARING POLYOLEFIN USING THE SAME | LG CHEM, LTD. (KR) | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180079841-A1 | METALLOCENE SUPPORTED CATALYST AND METHOD FOR PREPARING POLYOLEFIN USING THE SAME | PCBP1, SOD1, PCLAF | GSK3B 4262/4885CDK1 2326/4885CCNB2 1613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.